Wise's Profit Falls Despite Top-Line Growth
ADMA BiologicsADMA Biologics(US:ADMA) WSJ·2025-11-06 08:22

Core Insights - The company's pretax profit experienced a decline of 13%, attributed in part to increased administrative expenses, including hiring [1] - Despite the drop in pretax profit, the underlying income showed a positive trend, increasing by 13% [1] Financial Performance - Pretax profit decreased by 13% due to higher administrative costs [1] - Underlying income rose by 13%, indicating a potential strength in operational performance despite the profit decline [1]